Literature DB >> 11868615

Reasons for the delays in the definitive diagnosis of lung cancer for more than one year from the recognition of abnormal chest shadows.

Akihiro Yoshimoto1, Hiroshi Tsuji, Eisuke Takazakura, Toshio Watanabe, Joji Haratake, Kazuo Kasahara, Masaki Fujimura, Shinji Nakao.   

Abstract

OBJECTIVE: Primary lung cancer generally has a poor prognosis if not diagnosed at an early stage. But some lung cancers grow very slowly. In particular, adenocarcinoma is sometimes observed for years with no change of tumor size. In this study, we examined the reasons for the delays in reaching a definitive diagnosis of lung cancer.
METHODS: We retrospectively reviewed primary lung cancer cases between January 1995 and December 1999 and examined those whose definitive diagnoses were delayed for more than a year.
RESULTS: A total of 222 primary lung cancers were diagnosed. Of those, 19 patients (group A, 8.6%) were diagnosed after more than a year, and the other 203 (group B, 91.4%) were diagnosed within one year. The proportion of women in group A was significantly higher than that in group B (p<0.05). The mean age of group A was significantly younger than that of group B (p<0.05). The Brinkman Index of group A was significantly lower than that of group B (p<0.05). The histologic types were significantly different between the two groups (p<0.05). In group A, 18 patients (94.7%) had adenocarcinomas. Five primary reasons for the delays in group A were identified: 1) Four patients were tentatively diagnosed as inflammation or benign tumor on CT and were consequently not followed-up. 2) The chest CT shadows in 6 patients were suspected lung cancers but transbronchial lung biopsy findings did not show malignancy. 3) Four patients were tentatively diagnosed as inflammation or benign tumor on CT, but the tumors showed only very slow growth or no change at all. 4) The chest CT shadows of 2 patients were suspected lung cancer, but the patients refused to undergo video-assisted thoracic surgery (VATS) or closer examination. 5) Three patients did not consult medical facilities for a second examination.
CONCLUSIONS: Many of the adenocarcinomas reviewed in our study grew slowly or remained unchanged for years. Doctors are mainly responsible for the delays in the definitive diagnosis and should aggressively perform VATS or closer examinations without hesitation.

Entities:  

Mesh:

Year:  2002        PMID: 11868615     DOI: 10.2169/internalmedicine.41.95

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  7 in total

1.  Characteristics and predictors of missed opportunities in lung cancer diagnosis: an electronic health record-based study.

Authors:  Hardeep Singh; Kamal Hirani; Himabindu Kadiyala; Olga Rudomiotov; Traber Davis; Myrna M Khan; Terry L Wahls
Journal:  J Clin Oncol       Date:  2010-06-07       Impact factor: 44.544

2.  Delay in surgical treatment of patients with hilar cholangiocarcinoma: does time impact outcomes?

Authors:  Anthony T Ruys; Simon G Heuts; Eric A Rauws; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2013-08-26       Impact factor: 3.647

3.  Multidisciplinary care in the oncology setting: historical perspective and data from lung and gynecology multidisciplinary clinics.

Authors:  Laura Elise Horvath; Edgardo Yordan; Deepak Malhotra; Ileana Leyva; Katy Bortel; Denise Schalk; Patricia Mellinger; Marianne Huml; Christy Kesslering; Jeffrey Huml
Journal:  J Oncol Pract       Date:  2010-11       Impact factor: 3.840

4.  Nanodelivery of MRI contrast agent enhances sensitivity of detection of lung cancer metastases.

Authors:  Matthew Freedman; Esther H Chang; Qi Zhou; Kathleen F Pirollo
Journal:  Acad Radiol       Date:  2009-05       Impact factor: 3.173

5.  Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: Cancer.

Authors:  V L Allgar; R D Neal
Journal:  Br J Cancer       Date:  2005-06-06       Impact factor: 7.640

6.  A retrospective analysis of delays in the diagnosis of lung cancer and associated costs.

Authors:  Thomas R Gildea; Stacey DaCosta Byfield; D Kyle Hogarth; David S Wilson; Curtis C Quinn
Journal:  Clinicoecon Outcomes Res       Date:  2017-05-12

7.  Do diagnostic delays in cancer matter?

Authors:  R D Neal
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.